​

Avalo Therapeutics Ownership | Who Owns Avalo Therapeutics?

OverviewForecastRevenueFinancialsChart

Avalo Therapeutics Ownership Summary

Avalo Therapeutics is owned by 72.42% institutional investors, 5.26% insiders, and 22.32% retail investors. Bvf inc/il is the largest institutional shareholder, holding 9.49% of AVTX shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.05% of its assets in Avalo Therapeutics shares.

AVTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAvalo Therapeutics72.42%5.26%22.32%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bvf inc/il1.03M9.49%$5.13M
Nantahala capital management995.00K9.19%$4.97M
Orbimed advisors967.00K8.93%$4.83M
Ra capital management932.97K8.61%$4.66M
Affinity asset advisors607.87K5.61%$3.03M
Deep track capital, lp567.10K5.24%$2.83M
Tcg crossover management483.00K4.46%$2.41M
Blackrock funding, inc. /de155.90K1.44%$777.94K
Perceptive advisors139.67K1.29%$696.94K
Adar1 capital management104.73K0.97%$522.60K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Allostery investments lp9.00K0.57%$44.91K
Affinity asset advisors607.87K0.41%$3.03M
Tcg crossover management483.00K0.28%$2.41M
Nantahala capital management995.00K0.19%$4.97M
Bvf inc/il1.03M0.18%$5.13M
Sio capital management72.17K0.14%$360.14K
Orbimed advisors967.00K0.12%$4.83M
Deep track capital, lp567.10K0.09%$2.83M
Adar1 capital management104.73K0.08%$522.60K
Ra capital management932.97K0.08%$4.66M

Top Buyers

HolderShares% AssetsChange
Nantahala capital management995.00K0.19%95.00K
Adar1 capital management104.73K0.08%94.73K
Blackrock funding, inc. /de155.90K-22.17K
Boothbay fund management11.32K0.00%11.32K
Quadrature capital10.98K0.00%10.98K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors139.67K0.03%-380.33K
Deep track capital, lp567.10K0.09%-292.77K
Ikarian capital35.30K0.03%-164.70K
Allostery investments lp9.00K0.57%-98.14K
Affinity asset advisors607.87K0.41%-49.28K

New Positions

HolderShares% AssetsChangeValue
Quadrature capital10.98K0.00%10.98K$54.77K
Pfs partners1.00K0.01%1.00K$12.71K
Raymond james financial1.00-1.00$5.00

Sold Out

HolderChange
Hrt financial lp-10.29K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025356.06%7,843,040-4.99%721.18%13-13.33%12200.00%
Mar 31, 202533-8,255,0579.62%781.52%15-11.76%433.33%
Dec 31, 20243317.86%7,530,52113.12%711.07%1730.77%3200.00%
Sep 30, 20242833.33%6,656,933763.30%8191.00%1318.18%1-75.00%
Jun 30, 20242116.67%771,102781.19%9818.57%11-4-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr113.90K1.05%-51.90K
abrdn Life Sciences Investors72.80K0.55%72.80K
Fidelity Extended Market Index52.95K0.40%-224.00
Extended Equity Market Fund K19.15K0.18%-382.00
iShares Micro-Cap ETF21.12K0.16%-
Fidelity Total Market Index18.59K0.14%-40.00
NT Ext Equity Mkt Idx Fd - NL11.56K0.11%-
Fidelity Series Total Market Index13.40K0.10%-
Spartan Extended Market Index Pool F13.10K0.10%435.00
NT Ext Equity Mkt Idx Fd - L10.61K0.10%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 13, 2024Almenoff June Sherie-Buy$6.50K
Nov 12, 2024Almenoff June Sherie-Buy$6.25K
Jun 26, 2023ARMISTICE CAPITAL, LLC-Sell$1.68M
Jun 27, 2023ARMISTICE CAPITAL, LLC-Sell$486.89K
Jun 26, 2023Caissa Capital Management ltd.-Sell$113.03K

Insider Transactions Trends

DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q42-

AVTX Ownership FAQ

Who Owns Avalo Therapeutics?

Avalo Therapeutics shareholders are primarily institutional investors at 72.42%, followed by 5.26% insiders and 22.32% retail investors. The average institutional ownership in Avalo Therapeutics's industry, Biotech Stocks , is 307.10%, which Avalo Therapeutics falls below.

Who owns the most shares of Avalo Therapeutics?

Avalo Therapeutics’s largest shareholders are Bvf inc/il (1.03M shares, 9.49%), Nantahala capital management (995K shares, 9.19%), and Orbimed advisors (967K shares, 8.93%). Together, they hold 27.61% of Avalo Therapeutics’s total shares outstanding.

Does Blackrock own Avalo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Avalo Therapeutics.

Who is Avalo Therapeutics’s biggest shareholder by percentage of total assets invested?

Allostery investments lp is Avalo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 9K Avalo Therapeutics shares, valued at 44.91K$.

Who is the top mutual fund holder of Avalo Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Avalo Therapeutics shares, with 1.05% of its total shares outstanding invested in 113.9K Avalo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools